Continuing Improvements. Tell Us How We’re Driving! Send us Feedback

FDA staff questions J&J antibiotic studies »

Posted By STONERS 4 months, 1 week ago in Style
7.6

Scale of 1 to 10

Read: 217

Propped: 78

Comments: 3

Click Prop It to Raise Score
 Prop it

U.S. drug reviewers have "several major concerns" about effectiveness data supplied by Johnson & Johnson in a bid to win approval for expanded use of its Doribax antibiotic, according to documents released on Monday.

Read Full Story at news.yahoo.com »

3 Comments Report

Got a Story?

Story Tags ?

Groups Watching This

No groups are watching this story. Why not share it with your group?

Advertisement